| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Enfortumab vedotin-ejfv (Padcev) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Allergy Immunotherapy | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Epcoritamab-bysp (Epkinly) | 2026-01-12 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Gonadotropin Releasing Hormones (GnRHs) Analogs | 2026-01-12 |
| BCBS Highmark Penn Medicare Advantage | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-01-12 |
| BCBS Highmark Penn Medicare Advantage | Alpha-1 Proteinase Inhibitors | 2026-01-12 |
| BCBS Highmark Penn Medicare Advantage | Belantamab mafodotin (Blenrep) | 2026-01-12 |
| BCBS Highmark Penn Medicare Advantage | Gonadotropin Releasing Hormones (GnRHs) Analogs | 2026-01-12 |
| BCBS Highmark NY and West NY | Biofeedback | 2026-01-12 |